Particularly, SCF released by tumor cells can activate the c-KIT receptor expressed on mature MCs, increasing IL-17 expression and promoting an immunosuppressive TME characterized by the secretion of adenosine and the increase in Tregs cell infiltration in tumor samples [97]. Here, KITLG is linked to neoplasm.